Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Ferrosan AS |
---|---|
Information provided by: | Ferrosan AS |
ClinicalTrials.gov Identifier: | NCT00317655 |
The main purpose of this study is to investigate the ability of some dietary supplement products to affect general joint health and life quality in a selected population with back pain.
The study is randomized and double - blind, with parallel groups receiving treatment for a duration of 12 weeks.
Condition | Intervention | Phase |
---|---|---|
Back Pain |
Drug: Glucosamine sulphate Drug: Ginger Drug: Ginger-Avocado-Soya Drug: Ginger-ibuprofen |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Glucosamine Sulphate, Ginger, Ginger-Avocado-Soya and Ginger-Ibuprofen for Chronic Back Pain - a Randomized, Double Blind, Placebo-Controlled Clinical Investigation With Parallel Groups for 3 Months to Enlighten Joint Health |
Enrollment: | 175 |
Study Start Date: | April 2006 |
Study Completion Date: | April 2007 |
Ages Eligible for Study: | 30 Years to 85 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | Jointcare/Fe/1/DK, Eudractnr. 2005-002691-15 |
Study First Received: | April 23, 2006 |
Last Updated: | May 16, 2007 |
ClinicalTrials.gov Identifier: | NCT00317655 |
Health Authority: | Denmark: Danish Medicines Agency |
back pain |
Signs and Symptoms Ibuprofen Neurologic Manifestations Pain Back Pain |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Nervous System Diseases Physiological Effects of Drugs Cyclooxygenase Inhibitors Enzyme Inhibitors Pharmacologic Actions Analgesics, Non-Narcotic |
Sensory System Agents Therapeutic Uses Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |